Quick Answer
KALA BIO, Inc. reported Stockholders Equity of $12.33 million for fiscal year 2024.
KALA BIO, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $12.33M | +64.3% |
| 2023 | $7.50M | -60.5% |
| 2022 | $18.97M | +12.9% |
| 2021 | $16.80M | -83.2% |
| 2020 | $100.00M | +236.8% |
| 2019 | $29.69M | -71.7% |
| 2018 | $104.98M | +17.1% |
| 2017 | $89.68M | +202.2% |
| 2016 | -$87.76M | -54.9% |
| 2015 | -$56.66M | -39.1% |
| 2014 | -$40.72M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.66M | -226.3% | -170.3% |
| June 30, 2025 | -$3.21M | -123.4% | -156.2% |
| March 31, 2025 | $5.71M | -14.3% | -53.7% |
| December 31, 2024 | $12.33M | +64.3% | +79.8% |
| September 30, 2024 | $6.86M | -38.9% | -50.0% |
| June 30, 2024 | $13.72M | -21.6% | +105.9% |
| March 31, 2024 | $6.66M | -71.6% | -11.2% |
| December 31, 2023 | $7.50M | -60.5% | -33.1% |
- KALA BIO, Inc. showed an increase of +64.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2014–2024 period, KALA BIO, Inc.’s stockholders equity has grown by 130.3% (from -$40.72 million to $12.33 million).
- The most recent figure is from KALA BIO, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: